Tag:

Biosimilars

FDA Regulatory Transformation: Accelerated Biosimilar Licensing to Reduce Financial Burden

The U.S. Food and Drug Administration (FDA) has developed a new policy aimed at simplifying the regulatory pathway for biosimilars to accelerate their market...